Onset of HYPERREFLEXIA; SEIZURES; or COMA in a previously diagnosed pre-eclamptic patient (PRE-ECLAMPSIA).
A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)
A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
Maternal deaths resulting from complications of pregnancy and childbirth in a given population.
A syndrome of HEMOLYSIS, elevated liver ENZYMES, and low blood platelets count (THROMBOCYTOPENIA). HELLP syndrome is observed in pregnant women with PRE-ECLAMPSIA or ECLAMPSIA who also exhibit LIVER damage and abnormalities in BLOOD COAGULATION.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.
A condition in pregnant women with elevated systolic (>140 mm Hg) and diastolic (>90 mm Hg) blood pressure on at least two occasions 6 h apart. HYPERTENSION complicates 8-10% of all pregnancies, generally after 20 weeks of gestation. Gestational hypertension can be divided into several broad categories according to the complexity and associated symptoms, such as EDEMA; PROTEINURIA; SEIZURES; abnormalities in BLOOD COAGULATION and liver functions.
The co-occurrence of pregnancy and a cardiovascular disease. The disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.
A condition that is characterized by HEADACHE; SEIZURES; and visual loss with edema in the posterior aspects of the CEREBRAL HEMISPHERES, such as the BRAIN STEM. Generally, lesions involve the white matter (nerve fibers) but occasionally the grey matter (nerve cell bodies).
Premature separation of the normally implanted PLACENTA from the UTERUS. Signs of varying degree of severity include UTERINE BLEEDING, uterine MUSCLE HYPERTONIA, and FETAL DISTRESS or FETAL DEATH.
Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; SPONTANEOUS ABORTION; INDUCED ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO.

Obstetric and neonatal outcome following chronic hypertension in pregnancy among different ethnic groups. (1/2035)

We retrospectively studied pre-eclampsia rate and obstetric outcome in a cohort of 436 pregnancies amongst 318 women of different ethnic backgrounds attending an antenatal hypertension clinic from 1980-1997, identifying 152 women (213 pregnancies) with chronic essential hypertension. The ethnic breakdown was: White, 64 (30.0%) pregnancies in 48 (31.5%) women; Black/Afro-Caribbean, 79 (37.1%) pregnancies in 56 (36.8%) women; and Indo-Asians, 70 (32.3%) pregnancies in 48 (31.6%) women. The prevalences of pre-eclampsia in White, Black and Indo-Asian women were 17.2%, 12.7% and 18.6%, respectively (p = 0.58). Pregnancies of Indo-Asian women were of shorter gestation, and babies in this group also had lower birth weight and ponderal index compared to those of White and Black women (all p < 0.05). The proportions of overall perinatal mortality were 1.6% for Whites (1/64), 3.8% for Blacks (3/79) and 10.0% for Indo-Asians (7/70), suggesting increased risk in the Indo-Asian group. Indo-Asian women with chronic essential hypertension need careful antenatal care and observation during pregnancy.  (+info)

Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55 (sTNFp55) and subsequent risk of preeclampsia. (2/2035)

Preeclampsia is characterized by diffuse vascular endothelial dysfunction. Tumor necrosis factor-alpha (TNF-alpha), which plays a key role in the cytokine network responsible for immunoregulation, is also known to contribute to endothelial dysfunction and other metabolic disturbances noted in preeclampsia. Results from cross-sectional studies and one longitudinal study indicate that TNF-alpha (or its soluble receptor, sTNFp55) is increased in the peripheral circulation and amniotic fluid of women with preeclampsia as compared with normotensive women. Between December 1993 and August 1994, prediagnostic sTNFp55 concentrations (a marker of excessive TNF-alpha release) were measured in 35 women with preeclampsia and 222 normotensive women to determine whether elevations precede the clinical manifestation of the disorder. Logistic regression procedures were used to calculate maximum likelihood estimates of odds ratios and 95% confidence intervals. Mean second trimester (15-22 weeks' gestation) serum sTNFp55 concentrations, measured by enzyme-linked immunosorbent assay, were 14.4% higher in preeclamptic women than in normotensive controls (716.6 pg/ml (standard deviation 193.6) vs. 626.4 pg/ml (standard deviation 158.0); p = 0.003). The relative risk of preeclampsia increased across successively higher quintiles of sTNFp55 (odds ratios were 1.0, 1.3, 2.1, and 3.7, with the lowest quintile used as the referent; p for trend = 0.007). After adjustment for maternal age, adiposity, and parity, the relative risk between extreme quintiles was 3.3 (95% confidence interval 0.8-13.4). These findings indicate that the level of TNF-alpha in maternal circulation is increased prior to the clinical manifestation of the disorder, and they are consistent with the hypothesized role of cytokines in mediating endothelial dysfunction and the pathogenesis of preeclampsia. Further work is needed to identify modifiable risk factors for the excessive synthesis and release of TNF-alpha in pregnancy, and to assess whether lowering of TNF-alpha concentrations in pregnancy alters the incidence and severity of preeclampsia.  (+info)

Outcome of pregnancy in women with congenital shunt lesions. (3/2035)

OBJECTIVE: To evaluate the outcome of pregnancy in women with congenital shunt lesions. SETTING: Retrospective study in a tertiary care centre. METHODS: Pregnancy history was obtained by a standardised questionnaire and medical records were reviewed. PATIENTS: 175 women were identified, at a mean (SD) age of 42 (14) years. Pregnancies occurred in 126 women: 50 with an atrial septal defect, 22 with a ventricular septal defect, 22 with an atrioventricular septal defect, 19 with tetralogy of Fallot, and 13 with other complex shunt lesions. RESULTS: 309 pregnancies were reported by 126 woman (2.5 (1.6) pregnancies per woman). The shortening fraction of the systemic ventricle was 40 (8)%, and 98% were in New York Heart Association class I-II at last follow up. Spontaneous abortions occurred in 17% of pregnancies (abortion rate, 0.4 (0.9) per woman). Gestational age of the 241 newborn infants was 8.8 (0.8) months. There were no maternal deaths related to pregnancy. Pre-eclampsia and embolic events were observed in 1.3% and 0.6%, respectively of all pregnancies. Women with complex shunt lesions more often underwent caesarean section (70% v 15-30%, p = 0.005) and gave birth to smaller babies for equivalent gestation (2577 (671) g v 3016 (572) to 3207 (610) g, p < 0.05). The recurrence risk of congenital heart disease was 2.5%. CONCLUSIONS: The outcome of pregnancy is favourable in women with congenital shunt lesions if their functional class and their systolic ventricular function are good. Such patients can be reassured.  (+info)

Liver disease in pregnancy. (4/2035)

Acute viral hepatitis is the most common cause of jaundice in pregnancy. The course of acute hepatitis is unaffected by pregnancy, except in patients with hepatitis E and disseminated herpes simplex infections, in which maternal and fetal mortality rates are significantly increased. Chronic hepatitis B or C infections may be transmitted to neonates; however, hepatitis B virus transmission is effectively prevented with perinatal hepatitis B vaccination and prophylaxis with hepatitis B immune globulin. Cholelithiasis occurs in 6 percent of pregnancies; complications can safely be treated with surgery. Women with chronic liver disease or cirrhosis exhibit a higher risk of fetal loss during pregnancy. Preeclampsia is associated with HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome, acute fatty liver of pregnancy, and hepatic infarction and rupture. These rare diseases result in increased maternal and fetal mortality. Treatment involves prompt delivery, whereupon the liver disease quickly reverses. Therapy with penicillamine, trientine, prednisone or azathioprine can be safely continued during pregnancy.  (+info)

A strategy for reducing maternal mortality. (5/2035)

A confidential system of enquiry into maternal mortality was introduced in Malaysia in 1991. The methods used and the findings obtained up to 1994 are reported below and an outline is given of the resulting recommendations and actions.  (+info)

Expression of the erythropoietin receptor by trophoblast cellsin the human placenta. (6/2035)

Nonclassical sites of erythropoietin (EPO) and erythropoietin receptor (EPO-R) expression have been described that suggest new physiological roles for this hormone unrelated to erythropoiesis. The recent finding of EPO expression by trophoblast cells in the human placenta prompted us to consider whether these cells also express EPO-R. With use of immunocytochemistry, EPO-R was identified in villous and extravillous cytotrophoblast cells, as well as in the syncytiotrophoblast at all gestational ages. EPO-R was also expressed by cells within the villous core, including endothelial cells of fetoplacental blood vessels. Placental tissues and isolated and immunopurified trophoblast cells, as well as trophoblast-derived choriocarcinoma Jar cells, expressed immunoreactive EPO-R on Western blot. EPO-R mRNA was also detected in the same placental tissues and trophoblast cells by nested-primer reverse transcription-polymerase chain reaction. Finally, EPO-R was functional insofar as the receptor was phosphorylated on tyrosine residues in response to exogenous EPO treatment of cultured trophoblast or Jar cells. Thus, the present findings support the hypothesis that trophoblast cells of the human placenta express EPO-R. In view of these results, taken together with previous work demonstrating EPO expression by the same cells, an autocrine role for this hormone in the survival, proliferation, or differentiation of placental trophoblast cells is proposed.  (+info)

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. (7/2035)

Immune mechanisms and the renin-angiotensin system are implicated in preeclampsia. We investigated 25 preeclamptic patients and compared them with 12 normotensive pregnant women and 10 pregnant patients with essential hypertension. Antibodies were detected by the chronotropic responses to AT1 receptor-mediated stimulation of cultured neonatal rat cardiomyocytes coupled with receptor-specific antagonists. Immunoglobulin from all preeclamptic patients stimulated the AT1 receptor, whereas immunoglobulin from controls had no effect. The increased autoimmune activity decreased after delivery. Affinity-column purification and anti-human IgG and IgM antibody exposure implicated an IgG antibody directed at the AT1 receptor. Peptides corresponding to sites on the AT1 receptor's second extracellular loop abolished the stimulatory effect. Western blotting with purified patient IgG and a commercially obtained AT1 receptor antibody produced bands of identical molecular weight. Furthermore, confocal microscopy of vascular smooth muscle cells showed colocalization of purified patient IgG and AT1 receptor antibody. The protein kinase C (PKC) inhibitor calphostin C prevented the stimulatory effect. Our results suggest that preeclamptic patients develop stimulatory autoantibodies against the second extracellular AT1 receptor loop. The effect appears to be PKC-mediated. These novel autoantibodies may participate in the angiotensin II-induced vascular lesions in these patients.  (+info)

Color Doppler waveforms of maternal cervical internal carotid arteries in normotensive and preeclamptic gravidas. (8/2035)

The objective of this study was to investigate and determine fitted percentiles of blood flow resistance of cervical internal carotid arteries in normal pregnancies from gestational weeks 20 to 42 and to compare the resistance indices and mean velocities of the these arteries in normotensive and preeclamptic gravidas. A duplex color apparatus with pulsed Doppler ultrasound scanner (7.5 MHz) was used to determine the resistance index and mean velocity values of maternal cervical internal carotid arteries in 310 healthy singleton gravidas (group 1) and 74 singleton preeclamptic gravidas (group 2). The resistance index and mean velocity values of the maternal cervical internal carotid arteries decrease as the gestational age increases in normal gravidas, whereas in preeclamptic pregnancies these values are no different from those in normal gravidas during the second half of the gestational period.  (+info)

Eclampsia is a serious pregnancy complication characterized by the onset of seizures or convulsions in a woman who has already developed preeclampsia, which is a condition marked by high blood pressure and damage to organs such as the liver and kidneys. Eclampsia can occur before, during, or after delivery and is considered a medical emergency that requires immediate treatment. It can pose significant risks to both the mother and the baby, including premature birth, fetal growth restriction, and even maternal and fetal death.

The exact causes of eclampsia are not fully understood, but it is thought to be related to problems with the placenta and abnormal blood vessel development in the uterus. Risk factors for developing eclampsia include preexisting medical conditions such as chronic hypertension or diabetes, a history of preeclampsia or eclampsia in previous pregnancies, multiple gestation (carrying more than one baby), and certain genetic factors.

Treatment for eclampsia typically involves delivering the baby as soon as possible to prevent further complications. In some cases, medication may be given to manage seizures and prevent their recurrence. Close monitoring of both the mother and the baby is essential to ensure the best possible outcomes.

Magnesium Sulfate is an inorganic salt with the chemical formula MgSO4. It is often encountered as the heptahydrate sulfate mineral epsomite (MgSO4·7H2O), commonly called Epsom salts. Magnesium sulfate is used medically as a vasodilator, to treat constipation, and as an antidote for magnesium overdose or poisoning. It is also used in the preparation of skin for esthetic procedures and in the treatment of eclampsia, a serious complication of pregnancy characterized by seizures.

Pre-eclampsia is a pregnancy-related disorder, typically characterized by the onset of high blood pressure (hypertension) and damage to organs, such as the kidneys, after the 20th week of pregnancy. It is often accompanied by proteinuria, which is the presence of excess protein in the urine. Pre-eclampsia can lead to serious complications for both the mother and the baby if left untreated or unmanaged.

The exact causes of pre-eclampsia are not fully understood, but it is believed that placental issues, genetic factors, and immune system problems may contribute to its development. Risk factors include first-time pregnancies, history of pre-eclampsia in previous pregnancies, chronic hypertension, obesity, older age (35 or older), and assisted reproductive technology (ART) pregnancies.

Pre-eclampsia can progress to a more severe form called eclampsia, which is characterized by the onset of seizures. HELLP syndrome, another severe complication, involves hemolysis (breaking down of red blood cells), elevated liver enzymes, and low platelet count.

Early detection and management of pre-eclampsia are crucial to prevent severe complications. Regular prenatal care, including frequent blood pressure checks and urine tests, can help identify early signs of the condition. Treatment typically involves close monitoring, medication to lower blood pressure, corticosteroids to promote fetal lung maturity, and, in some cases, delivery of the baby if the mother's or baby's health is at risk.

Maternal mortality is defined by the World Health Organization (WHO) as "the death of a woman while pregnant or within 42 days of termination of pregnancy, irrespective of the duration and site of the pregnancy, from any cause related to or aggravated by the pregnancy or its management but not from accidental or incidental causes."

This definition highlights that maternal mortality is a preventable death that occurs during pregnancy, childbirth, or in the postpartum period, and it can be caused by various factors related to or worsened by the pregnancy or its management. The WHO also collects data on maternal deaths due to direct obstetric causes (such as hemorrhage, hypertensive disorders, sepsis, and unsafe abortion) and indirect causes (such as malaria, anemia, and HIV/AIDS).

Maternal mortality is a significant public health issue worldwide, particularly in low- and middle-income countries. Reducing maternal mortality is one of the Sustainable Development Goals (SDGs) set by the United Nations, with a target to reduce the global maternal mortality ratio to less than 70 per 100,000 live births by 2030.

HELLP syndrome is a serious complication in pregnancy, characterized by Hemolysis (the breakdown of red blood cells), Elevated Liver enzymes, and Low Platelet count. It is often considered a variant of severe preeclampsia or eclampsia, although it can also occur without these conditions.

The symptoms of HELLP syndrome include headache, nausea and vomiting, upper right abdominal pain, and visual disturbances. It can lead to serious complications for both the mother and the baby, such as liver failure, placental abruption, disseminated intravascular coagulation (DIC), and even death if not promptly diagnosed and treated.

The exact cause of HELLP syndrome is not known, but it is thought to be related to problems with the blood vessels that supply the placenta. Treatment typically involves delivering the baby as soon as possible, even if the baby is premature. Women who have had HELLP syndrome are at increased risk for complications in future pregnancies.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Puerperal disorders are a group of medical conditions that can affect women during the period following childbirth, also known as the puerperium. The puerperium typically lasts for six to eight weeks after delivery. These disorders can be complications of childbirth or postpartum infections and include:

1. Puerperal fever: This is a febrile illness that occurs during the puerperium, usually caused by a bacterial infection. The most common causative organisms are group A streptococcus, Staphylococcus aureus, and Escherichia coli.

2. Puerperal sepsis: This is a severe form of puerperal fever characterized by the presence of bacteria in the blood (bacteremia) and widespread inflammation throughout the body. It can lead to organ failure and even death if not treated promptly with antibiotics.

3. Puerperal endometritis: This is an infection of the lining of the uterus (endometrium) that occurs during the puerperium. Symptoms may include fever, abdominal pain, and foul-smelling vaginal discharge.

4. Puerperal mastitis: This is an inflammation of the breast tissue that can occur during lactation, often caused by a bacterial infection. It is more common in women who are breastfeeding but can also occur in non-lactating women.

5. Puerperal psychosis: This is a rare but serious mental health disorder that can occur after childbirth. It is characterized by symptoms such as delusions, hallucinations, and disorganized thinking.

6. Puerperal thromboembolism: This is a blood clot that forms during the puerperium, usually in the deep veins of the legs (deep vein thrombosis) or in the lungs (pulmonary embolism). It can be a serious complication of childbirth and requires prompt medical attention.

Overall, puerperal disorders are a significant cause of maternal morbidity and mortality worldwide, particularly in low-income countries where access to healthcare is limited. Prompt diagnosis and treatment are essential for improving outcomes and reducing the risk of long-term complications.

Pregnancy-induced hypertension (PIH), also known as gestational hypertension, is a condition characterized by the new onset of high blood pressure (≥140 mm Hg systolic or ≥90 mm Hg diastolic) after 20 weeks of pregnancy in a woman who was normotensive before. It can sometimes progress to more severe conditions like preeclampsia and eclampsia, which are associated with damage to other organ systems such as the liver and kidneys.

PIH is typically classified into two types:

1. Gestational hypertension: This is when a woman develops high blood pressure after 20 weeks of pregnancy without any protein in the urine or evidence of damage to other organ systems. Women with gestational hypertension are at increased risk for preeclampsia and may require closer monitoring.

2. Preeclampsia: This is a more severe form of PIH, characterized by high blood pressure and proteinuria (≥0.3 g in a 24-hour urine collection) after 20 weeks of pregnancy. Preeclampsia can also involve damage to other organ systems, such as the liver, kidneys, or brain, and may progress to eclampsia, a life-threatening condition characterized by seizures.

The exact causes of PIH are not fully understood, but it is thought to be related to problems with the development and function of the blood vessels that supply the placenta. Risk factors for developing PIH include first-time pregnancies, obesity, older age, a history of chronic hypertension or kidney disease, and carrying multiples (twins, triplets, etc.).

Treatment for PIH depends on the severity of the condition and the gestational age of the pregnancy. In mild cases, close monitoring of blood pressure, urine protein levels, and fetal growth may be sufficient. More severe cases may require medication to lower blood pressure, corticosteroids to promote fetal lung maturity, or early delivery of the baby to prevent further complications.

Cardiovascular complications in pregnancy refer to conditions that affect the heart and blood vessels, which can arise during pregnancy, childbirth, or after delivery. These complications can be pre-existing or new-onset and can range from mild to severe, potentially threatening the life of both the mother and the fetus. Some examples of cardiovascular complications in pregnancy include:

1. Hypertension disorders: This includes chronic hypertension (high blood pressure before pregnancy), gestational hypertension (high blood pressure that develops after 20 weeks of pregnancy), and preeclampsia/eclampsia (a pregnancy-specific disorder characterized by high blood pressure, proteinuria, and potential organ damage).

2. Cardiomyopathy: A condition in which the heart muscle becomes weakened, leading to an enlarged heart and reduced pumping efficiency. Peripartum cardiomyopathy is a specific type that occurs during pregnancy or in the months following delivery.

3. Arrhythmias: Irregularities in the heart's rhythm, such as tachycardia (rapid heartbeat) or bradycardia (slow heartbeat), can occur during pregnancy and may require medical intervention.

4. Valvular heart disease: Pre-existing valve disorders, like mitral stenosis or aortic insufficiency, can worsen during pregnancy due to increased blood volume and cardiac output. Additionally, new valve issues might develop during pregnancy.

5. Venous thromboembolism (VTE): Pregnancy increases the risk of developing blood clots in the veins, particularly deep vein thrombosis (DVT) or pulmonary embolism (PE).

6. Ischemic heart disease: Although rare, coronary artery disease and acute coronary syndrome can occur during pregnancy, especially in women with risk factors such as obesity, diabetes, or smoking history.

7. Heart failure: Severe cardiac dysfunction leading to fluid accumulation, shortness of breath, and reduced exercise tolerance may develop due to any of the above conditions or other underlying heart diseases.

Early recognition, monitoring, and appropriate management of these cardiovascular complications in pregnancy are crucial for maternal and fetal well-being.

Posterior Leukoencephalopathy Syndrome (PLS) is a neurological disorder characterized by the presence of vasogenic edema (swelling due to leakage of fluid from blood vessels) in the white matter (part of the brain that contains nerve fibers) of the posterior regions (occipital and parietal lobes) of the brain.

The symptoms of PLS can vary but often include headache, altered mental status, seizures, visual disturbances, and hypertension (high blood pressure). The exact cause of PLS is not fully understood, but it has been associated with certain conditions such as eclampsia, preeclampsia, kidney failure, autoimmune disorders, and the use of certain medications.

PLS is typically diagnosed based on clinical symptoms and imaging studies such as MRI or CT scans. Treatment usually involves addressing the underlying cause of PLS, controlling hypertension if present, and managing seizures if they occur. With prompt and appropriate treatment, most patients with PLS have a good prognosis and recover completely. However, in severe cases, PLS can lead to permanent neurological damage or even death.

Abruptio placentae, also known as placental abruption, is a medical condition that occurs when the placenta separates from the uterus before the baby is born. The placenta is an organ that develops in the uterus during pregnancy to provide oxygen and nutrients to the growing fetus.

In abruptio placentae, the separation of the placenta from the uterus can cause bleeding, which can be serious or life-threatening for both the mother and the baby. The severity of the condition depends on how much of the placenta has separated from the uterus and how much bleeding has occurred.

Abruptio placentae can cause a range of symptoms, including vaginal bleeding, abdominal pain, contractions, and fetal distress. In severe cases, it can lead to preterm labor, low birth weight, and even stillbirth. The exact cause of abruptio placentae is not always known, but risk factors include high blood pressure, smoking, cocaine use, trauma to the abdomen, and advanced maternal age. Treatment may involve hospitalization, bed rest, medication to prevent contractions, or delivery of the baby if the pregnancy is at term.

Pregnancy outcome refers to the final result or status of a pregnancy, including both the health of the mother and the newborn baby. It can be categorized into various types such as:

1. Live birth: The delivery of one or more babies who show signs of life after separation from their mother.
2. Stillbirth: The delivery of a baby who has died in the womb after 20 weeks of pregnancy.
3. Miscarriage: The spontaneous loss of a pregnancy before the 20th week.
4. Abortion: The intentional termination of a pregnancy before the fetus can survive outside the uterus.
5. Ectopic pregnancy: A pregnancy that develops outside the uterus, usually in the fallopian tube, which is not viable and requires medical attention.
6. Preterm birth: The delivery of a baby before 37 weeks of gestation, which can lead to various health issues for the newborn.
7. Full-term birth: The delivery of a baby between 37 and 42 weeks of gestation.
8. Post-term pregnancy: The delivery of a baby after 42 weeks of gestation, which may increase the risk of complications for both mother and baby.

The pregnancy outcome is influenced by various factors such as maternal age, health status, lifestyle habits, genetic factors, and access to quality prenatal care.

Commonly, pre-eclampsia continues into the period after delivery, then known as postpartum pre-eclampsia. Rarely, pre-eclampsia ... "Pre-eclampsia-Eclampsia". Diagnosis and management of pre-eclampsia and eclampsia. Armenian Medical Network. 2003. Retrieved ... Complications of pre-eclampsia can affect both the mother and the fetus. Acutely, pre-eclampsia can be complicated by eclampsia ... and that ultimately results in pre-eclampsia and eclampsia. One hypothesis for vulnerability to pre-eclampsia is the maternal- ...
... is the onset of seizures (convulsions) in a woman with pre-eclampsia. Pre-eclampsia is a hypertensive disorder of ... Because pre-eclampsia and eclampsia are common conditions in women, eclampsia can be assumed to be the correct diagnosis until ... Patients who have experienced eclampsia are at increased risk for pre-eclampsia/eclampsia in a later pregnancy. The occurrence ... Pre-eclampsia is estimated to globally affect about 5% of deliveries while eclampsia affects about 1.4% of deliveries. In the ...
Action on Pre-Eclampsia; Herts Aid; Crucial Crew; The Friends of the Forster Country In 2001, Follett appeared in the ... Follett is also an alumna of the Open University and she has since become a patron of Action on Pre-Eclampsia. The 1997 General ...
"Cure for pre-eclampsia? Birmingham scientist offers hope for millions of women". 28 October 2020. Aston Medical School "Aston ... Ahmed's laboratory has studied vascular growth factors in pregnancy and preeclampsia. Research topics include the enzyme ... "Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia". Circulation. 124 (4): 940-50. doi ... lyase Contributes to Maternal Hypertension and Placental Abnormalities in Preeclampsia". Circulation. 127 (25): 2514-22. doi: ...
"Preeclampsia". babycenter. Page, Nigel M (2010). "Neurokinin B and pre-eclampsia: a decade of discovery". Reproductive Biology ... The cause of pre-eclampsia is not known. Research indicates that the tachykinin peptide neurokinin B may play a role, as ... Pre-eclampsia is a disorder found in around 5% of pregnant women, usually presenting in the 37th week of gestation, with ... In most cases of pre-eclampsia, the trophoblast was unable to fully invade into the uterine lining and has been an almost ...
Pre-eclampsia is a disease defined by a combination of signs and symptoms that are related to maternal hypertension. The cause ... Women may still develop pre-eclampsia following delivery. Placental abruption is where the placenta detaches from the uterus ... Reasons to induce can include pre-eclampsia, foetal distress, placental malfunction, intrauterine growth retardation and ... Gaither K (13 December 2019). "Preeclampsia". WebMD. Retrieved 2022-04-29. "Preeclampsia - Symptoms and causes". Mayo Clinic. ...
This includes medical conditions like gestational hypertension and pre-eclampsia. Postpartum infections are infections of the ... Maternal death due to eclampsia can also be prevented through the use of medications such as magnesium sulfate. Many ... The majority of these were due to severe bleeding, sepsis or infections, eclampsia, obstructed labor, and consequences from ... Eiland, Elosha; Nzerue, Chike; Faulkner, Marquetta (2012). "Preeclampsia 2012". Journal of Pregnancy. 2012: 586578. doi:10.1155 ...
Untreated, preeclampsia can progress and turn into eclampsia which is much more severe with the addition of seizures. Eclampsia ... Peres GM, Mariana M, Cairrão E (January 2018). "Pre-Eclampsia and Eclampsia: An Update on the Pharmacological Treatment Applied ... of Pre-Eclampsia Consortium in the United Kingdom found that smokers were five times more likely to develop pre-eclampsia. ... Placental insufficiency as a result of smoking has been shown to have a causal effect in the development of pre-eclampsia. ...
... pregnancy-induced hypertension and pre-eclampsia; miscarriage; infertility; and type 2 diabetes mellitus. There has also been ... May 2019). "Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis". BMC ... one of the biggest being pre-existing mental health issues prior to getting an abortion. One systematic review found a clear ... and a 1.71 increased risk of preeclampsia among women. Success rates for ART are improving yet vary significantly and are ...
"COMMUNITY-LEVEL INTERVENTIONS FOR PRE-ECLAMPSIA". PRE-EMPT CO-ORDINATING CENTRE. 29 September 2015. Official SDK Site Github ...
Varas Enriquez PJ, McKerracher LJ, Elliot MG (2018-01-01). "Pre-eclampsia and maternal-fetal conflict". Evolution, Medicine, ...
ISBN 978-1-60913-713-7. Arulkumaran N, Lightstone L (December 2013). "Severe pre-eclampsia and hypertensive crises". Best ... has a particular indication in the treatment of pregnancy-induced hypertension which is commonly associated with pre-eclampsia ...
mate choice and disease susceptibility genomic conflict between mother and fetus that results in pre-eclampsia Humans evolved ... Schuiling GA (September 2000). "Pre-eclampsia: a parent-offspring conflict". Journal of Psychosomatic Obstetrics and ...
Clinical symptoms of pre-eclampsia in the mother are most commonly high blood pressure, proteinuria and edema. Conversely, if ... The most common associated disorder is pre-eclampsia, affecting approximately 7% of all births. It is characterized by a ... Genbacev, O., DiFederico, E., McMaster, M., & Fisher, S. (1999). "Invasive cytotrophoblast apoptosis in pre-eclampsia." Human ...
It is highly associated with known pre-eclampsia. Risk factors for pre-eclampsia include older age, uncontrolled hypertension, ... HELLP syndrome occurs in about 0.7% of pregnancies and affects about 15% of women with eclampsia or severe pre-eclampsia. Death ... The condition occurs in association with pre-eclampsia or eclampsia. Other risk factors include previously having the syndrome ... "Preeclampsia and Eclampsia". Merck Manuals Consumer Version. March 2018. Retrieved 5 October 2018. Sibai BM, Taslimi MM, el- ...
Any pregnancy resulting from an encounter with a stranger carries a higher risk of pre-eclampsia, the condition in which ... Preeclampsia: Risk Factors. Mayo Clinic. Retrieved on 2012-08-22. Wingood, G; DiClemente, R; Raj, A. (2000). "Adverse ...
Lu JF, Nightingale CH (2000). "Magnesium sulfate in eclampsia and pre-eclampsia". Clin Pharmacokinet. 38 (4): 305-314. doi: ... Magnesium toxicity from emergency pre-eclampsia treatment during labor and delivery. Other conditions that can predispose to ... For instance, during the management of eclampsia, the magnesium infusion is stopped if urine output drops to less than 80 mL ( ... 281 The therapeutic range for the prevention of the pre-eclamptic uterine contractions is: 4.0-7.0 mEq/L. As per Lu and ...
"Maternal health: Vitamin D in pre-eclampsia". openaccessgovernment.org. 9 November 2021. Retrieved 11 November 2022. "What Is ... "What happens if you're diagnosed with pre-eclampsia?". goodto.com. 24 May 2022. Retrieved 11 November 2022. Charley Ward," ...
Maternal health, including: treatment and prevention of obstetric fistula; treatment and prevention of pre-eclampsia/eclampsia ...
... eclampsia and hypothyroidism. In most cases, most case reports discuss the prevalence of preeclampsia and preterm contractions ... that have been associated with abnormally raised levels of hCG can be seen in the potential development of pre-eclampsia, HELLP ... People who are of pre- and postmenopausal age with breast cancer and are being treated with tamoxifen are at increased risk for ... Gatongi DK, Madhvi G, Tydeman G, Hasan A (July 2006). "A case of hyperreactio luteinalis presenting with eclampsia". Journal of ...
... she developed pre-eclampsia. Then she went into labour three weeks early and had to have an emergency Caesarean section. Her ...
While generally benign, it may herald three complications of pregnancy: pre-eclampsia, HELLP syndrome and eclampsia. Follow-up ... Kang A, Struben H (November 2008). "[Pre-eclampsia screening in first and second trimester]". Therapeutische Umschau (in German ...
Its effects on pre-eclampsia, low birthweight and fetal distress during labour are unclear. Abdominal decompression consists of ... Hofmeyr, GJ (13 June 2012). "Abdominal decompression for suspected fetal compromise/pre-eclampsia". The Cochrane Database of ...
Her research considered the pathogenesis of pre-eclampsia. In 2005 Knight established the UK Obstetric Surveillance System, a ... Knight, Marian (1997). Syncytiotrophoblast microvillous membrane deportation in the pathogenesis of pre-eclampsia (Thesis). ...
Ling L (Feb 2014). "Evaluation of plasma endothelial microparticles in pre-eclampsia". J Int Med Res. 42 (1): 42-51. doi: ... and pre-eclampsia and various forms of vasculitis. The endothelial microparticles in some of these disease states have been ... can be employed to reverse many tumors in pre-clinical cancer models, and may be used in combination with chemotherapy. ...
Failure of this to occur can lead to miscarriage or pre-eclampsia. Croy, B. Anne; He, Hong; Esadeg, Souad; Wei, Qingxia; ... Cudihy, D.; Lee, R. V. (2009-01-01). "The pathophysiology of pre-eclampsia: Current clinical concepts". Journal of Obstetrics ...
Eclampsia: Eclampsia is a more severe form of preeclampsia, marked by seizures and coma in the mother. HELLP Syndrome ... WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva, Switzerland: World Health Organization ... and pre-term birth. Pre-existing diabetes - Pre-existing diabetes that is not managed during pregnancy is associated with ... Hypertension is considered a risk factor for high-risk pregnancy because it leads to an increased risk of pre-eclampsia, ...
Hyperammonemia Eclampsia and, rarely, pre-eclampsia The most common causes of congenital cortical blindness are: Traumatic ... Cunningham, F. G.; Fernandez, C. O.; Hernandez, C. (1995). "Blindness associated with preeclampsia and eclampsia". American ... Do, D. V.; Rismondo, V.; Nguyen, Q. D. (2002). "Reversible cortical blindness in preeclampsia". American Journal of ... Hyperammonemia~followup at eMedicine Cipolla MJ (July 2007). "Cerebrovascular function in pregnancy and eclampsia". ...
Pre-eclampsia - Demonstrated a disturbance of ascorbic acid metabolism in pre-eclampsia and in abruptio placentae. Methodist ... Demonstrated aortic hypoplasia in some patients following severe early pre-eclampsia. Performed and published successful open ... 1956-1958 Demonstrated the effects of cord around the neck and of pre-eclampsia on the oxygen saturation of newborn infants. ... metabolism and depletion in pre-eclampsia. After Clemetson's retirement from teaching in 1991, his work focused on developing ...
Eclampsia is the onset of seizures (convulsions) in a woman with pre-eclampsia. Pre-eclampsia is a disorder of pregnancy in ... Pre-eclampsia is routinely screened for during prenatal care. Onset may be before, during, or rarely, after delivery. Around ... The fourth stage of labour involves recovery, the uterus beginning to contract to pre-pregnancy state, delayed clamping of the ... Gestational hypertension Maternal conditions such as gestational diabetes or chronic kidney disease Preeclampsia or eclampsia ...
Commonly, pre-eclampsia continues into the period after delivery, then known as postpartum pre-eclampsia. Rarely, pre-eclampsia ... "Pre-eclampsia-Eclampsia". Diagnosis and management of pre-eclampsia and eclampsia. Armenian Medical Network. 2003. Retrieved ... Complications of pre-eclampsia can affect both the mother and the fetus. Acutely, pre-eclampsia can be complicated by eclampsia ... and that ultimately results in pre-eclampsia and eclampsia. One hypothesis for vulnerability to pre-eclampsia is the maternal- ...
Preeclampsia is a complication of pregnancy in which affected women develop high blood pressure ( hypertension ); they can also ... High Risk of Pre-eclampsia Identification Group. Clinical risk factors for pre-eclampsia determined in early pregnancy: ... About 1 in 200 women with untreated preeclampsia develop eclampsia. Eclampsia can also develop without any obvious signs of ... Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic ...
Preeclampsia is a disorder of widespread vascular endothelial malfunction and vasospasm that occurs after 20 weeks gestation ... Preeclampsia/eclampsia. Preeclampsia/eclampsia is characterized by a BP of 140/90 mm Hg or greater after 20 weeks gestation in ... Evaluation of Preeclampsia. Because the clinical manifestations of preeclampsia can be heterogeneous, diagnosing preeclampsia ... Preeclampsia and preeclampsia with severe features. Severe preeclampsia accounts for approximately 25% of all cases of ...
Preeclampsia is a disorder of widespread vascular endothelial malfunction and vasospasm that occurs after 20 weeks gestation ... Preeclampsia/eclampsia. Preeclampsia/eclampsia is characterized by a BP of 140/90 mm Hg or greater after 20 weeks gestation in ... Evaluation of Preeclampsia. Because the clinical manifestations of preeclampsia can be heterogeneous, diagnosing preeclampsia ... Preeclampsia and preeclampsia with severe features. Severe preeclampsia accounts for approximately 25% of all cases of ...
Doctors keep searching for a magic bullet to cure pre-eclampsia. But evidence suggests the best preventative is a good diet ... these symptoms generally indicate pre-eclampsia; singly, they do not usually pose a threat.. If early symptoms of pre-eclampsia ... The women on low salt diets had much higher rates of pre-eclampsia and eclampsia, as well as higher rates of miscarriage, ... However, one in 2000 cases of pre-eclampsia can develop into eclampsia, a potentially lethal condition for both mother and baby ...
In this review, we detail these effects and their relationship to preeclampsia (PE) and intrauterine growth restriction (IUGR). ... "The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community," British ... L. Duley, "Pre-eclampsia and the hypertensive disorders of pregnancy," British Medical Bulletin, vol. 67, pp. 161-176, 2003. ... E. A. P. Steegers, P. von Dadelszen, J. J. Duvekot, and R. Pijnenborg, "Pre-eclampsia," The Lancet, vol. 376, no. 9741, pp. 631 ...
GlobalNews.ca your source for the latest news on Preeclampsia . ... developing a major pregnancy complication such as pre-eclampsia ... Preeclampsia. * Calgary woman on mission to prevent preeclampsia deaths after losing her daughter ... Having preeclampsia can double a womans risk of heart disease Its a relatively common thing during pregnancy - but it can ...
Postpartum preeclampsia is a rare condition where women develop preeclampsia after birth. Symptoms often develop within 48 ... Eclampsia. Eclampsia is a rare but serious condition that causes seizures during pregnancy. Eclampsia affects about 1 in every ... Postpartum preeclampsia is one such risk. You can develop it even if you didnt have preeclampsia or high blood pressure during ... About preeclampsia and eclampsia. (2018).. https://www.nichd.nih.gov/health/topics/preeclampsia/conditioninfo. ...
... If left untreated, pre-eclampsia is a condition that can have severe consequences on pregnancies. A ... After being diagnosed with pre-eclampsia. The early symptoms of pre-eclampsia (high blood pressure and proteinuria) are ... This article addresses the treatment of pre-eclampsia, and provides information on what to expect if you have been diagnosed ... pre-eclampsia is thought to result as a consequence of the abnormal development of the placenta, an organ responsible for ...
Pregnant women who eat organic vegetables regularly may face a lower risk of pregnancy complication pre-eclampsia than those ... of the women involved developed pre-eclampsia. Those who ate organic vegetables often or mostly had a 24% lower risk of pre ... Organic vegetables may help reduce pregnancy pre-eclampsia risk: Research. By Anna Bonar 30-Sep-2014. - Last updated on 01-Oct- ... Pre-eclampsia is a complication occurring in late stages of pregnancy, characterised by high blood pressure and protein ...
Pregnancy Worries: Symptoms of Proteinuria and Pre-eclampsia Thousands of unborn babies and women get very ill each year and ... many die from a condition that can become very dangerous called pre-eclampsia. This ...
Prospective cohort study in Cape Town, South Africa, involving 113 women with severe pre-eclampsia between 24 and 34 weeks of ... the estimated fetal weight at the time of diagnosis is the most important prognostic factor in severe pre-eclampsia with some ... Assess the prognostic value of ultrasound and Doppler parameters in severe preterm pre-eclampsia. ... Severe early onset pre-eclampsia: prognostic value of ultrasound and Doppler assessment. *L Geerts. 1 & ...
The USPSTF recommends screening for preeclampsia in pregnant women with blood pressure measurements throughout pregnancy. ... Pregnancy-related mortality from pre-eclampsia and eclampsia. Obstet Gynecol. 2001;97(4):533-538. ... Important clinical conditions associated with increased risk for preeclampsia include a history of eclampsia or preeclampsia ( ... Redman C. Pre-eclampsia: a complex and variable disease. Pregnancy Hypertens. 2014;4(3):241-242. ...
Breakdown of immune tolerance may result in sterile inflammation and cause adverse pregnancy outcomes such as preeclampsia, a ... In this mini-review genetic variation in immunological factors are discussed in the context of preeclampsia. Specifically, we ... In this mini-review genetic variation in immunological factors are discussed in the context of preeclampsia. Specifically, we ... Immunological incompatibility between mother and fetus is strongly indicated in preeclampsia. Recently, genetic factors linking ...
Have you suffered with preeclampsia or eclampsia as a pregnant mother due to a medical professionals negligence? If so, ... Causes of preeclampsia and eclampsia. Although the specific causes of preeclampsia and eclampsia are unknown at the present ... preeclampsia may lead to eclampsia, condition causing seizures. Both preeclampsia and eclampsia are very serious health ... Eclampsia and its symptoms. Eclampsia is a severe complication of preeclampsia characterized by one or more seizures during or ...
A recent study identified a cell free RNA (cfRNA) signature that was promising in predicting pre-eclampsia several weeks before ... At 29 weeks pregnant, Erica was diagnosed with preeclampsia, a pregnancy complication marked by high blood pressure and signs ...
Preeclampsia occurs in about 6% of the general population; the incidence varies with geographic location ... Preeclampsia *Eclampsia L Pathophysiology L Clinical Findings L Treatment L Prognosis *Chronic Hypertension L Clinical Findings ... Eclampsia cannot always be prevented. Patients may deteriorate suddenly and without warning. Treatment. A. Mild Preeclampsia. 1 ... Most patients with preeclampsia-eclampsia have normal clotting studies. In some, a spectrum of abnormalities may be found, ...
If a woman with severe preeclampsia develops seizures, her condition is then called eclampsia. ... According to The Preeclampsia Foundation, preeclampsia can:. * Cause your blood pressure to rise and put you at risk of brain ... Causes of Preeclampsia. Experts dont know exactly what causes preeclampsia, but risk factors include:. * Being African ... High blood pressure is, however, among the hallmark signs of preeclampsia. Other symptoms of preeclampsia include:. * Protein ...
... such as eclampsia and maternal death, rarely occurred in studies and could not be evaluated. ... Aspirin use was recommended for patients with one or more high risk factors for preeclampsia, including history of preeclampsia ... Preeclampsia is one of the most serious health complications of pregnancy, and affects approximately 4% of pregnancies in the U ... These updated guidelines reaffirm the USPSTFs 2014 recommendation on low-dose aspirin use for preeclampsia prevention, and add ...
Latest NICE guidelines advise pregnant women receive a new check to identify pre-eclampsia earlier ... What happens if I have pre-eclampsia?. If your midwives think you are at a risk of pre-eclampsia, they might advise you to take ... New pre-eclampsia check recommended. Latest NICE guidelines advise pregnant women receive a new check to identify pre-eclampsia ... Pre-eclampsia check advised for pregnant women. New guidelines advise a simple test to help spot pre-eclampsia earlier ...
Find out what increases your chance of developing pre-eclampsia and discover our experts tips on ways to prevent pre-eclampsia ... Your chance of developing pre-eclampsia is much higher if you: *had high blood pressure or pre-eclampsia in a previous ... Pre-eclampsia can start at any time in the second half of your pregnancy. The vast majority of cases are detected in the early ... The difficulty with pre-eclampsia is that you can develop it and feel perfectly well at the same time. Thats why your midwife ...
Preeclampsia, Pregnancy Induced Hypertension, HELLP syndrome, eclampsia, hypertensive disorders of pregnancy ... Preeclampsia and related disorders such as gestational hypertension, HELLP syndrome, and eclampsia are most often characterized ... Join the Journey to stop preeclampsia by making a gift this season! There are many ways you can support education, healthcare, ... Thousands of women and babies get very sick each year from a dangerous condition called preeclampsia, a life-threatening ...
Preeclampsia, Pregnancy Induced Hypertension, HELLP syndrome, eclampsia, hypertensive disorders of pregnancy ... Preeclampsia and related disorders such as gestational hypertension, HELLP syndrome, and eclampsia are most often characterized ... Join the Journey to stop preeclampsia by making a gift this season! There are many ways you can support education, healthcare, ... Thousands of women and babies get very sick each year from a dangerous condition called preeclampsia, a life-threatening ...
Preeclampsia, Pregnancy Induced Hypertension, HELLP syndrome, eclampsia, hypertensive disorders of pregnancy ... Preeclampsia and related disorders such as gestational hypertension, HELLP syndrome, and eclampsia are most often characterized ... Join the Journey to stop preeclampsia by making a gift this season! There are many ways you can support education, healthcare, ... Thousands of women and babies get very sick each year from a dangerous condition called preeclampsia, a life-threatening ...
Induction Due Pre-eclampsia It was very intense but I was able to stay completely relaxed, focused and comfortable with ... allowing the pre-eclampsia to progress) because the worse it gets the harder it is on the baby and me. They said moms with pre- ... Taylors Hypnobabies Birth, an Induction Due to Pre-eclampsia. Last updated on June 13, 2022 imaginemonkey Hospital Birth, ... I was diagnosed with pre-eclampsia and preterm labor at 31 weeks and was told that I would likely be having my baby within 1-2 ...
... have never heard of pre-eclampsia before finding themselves at risk of developing it. Our research is working to predict the ... Pre-eclampsia also has the potential to progress into a more dangerous condition known as eclampsia, which occurs in 1-2 ... Home About us News & views Tommys is tackling pre-eclampsia to help mums at risk ... Pre-eclampsia is a condition which occurs in pregnancy and can be dangerous for both you and your baby if it is left untreated. ...
Pre-Eclampsia Therapeutics, Global, Clinical Trials by Region, 2021*. *Pre-Eclampsia Therapeutics, Global, Clinical Trials and ... Pre-Eclampsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2021*. *Pre-Eclampsia Therapeutics, G7 Countries, Clinical ... Pre-Eclampsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2021*. *Pre-Eclampsia Therapeutics, E7 Countries, Clinical ... Pre-Eclampsia Therapeutics, Global, Clinical Trials by Phase, 2021*. *Pre-Eclampsia Therapeutics, Global, Clinical Trials In ...
Eclampsia is a condition where a patient experiences seizures during pregnancy or after birth. ... "Preeclampsia is a very common disorder, and a lot of people are not aware of its association with stroke," Dr Miller said. " ... "Preeclampsia is a very complex disorder thats not completely understood," said lead study author Eliza Miller, MD. "Our study ... Patients with preeclampsia have a high risk of experiencing stroke both during pregnancy and after delivery; however, pregnancy ...
New research may have found a link between vitamin D and early-onset severe preeclampsia. The dangerous condition, which ... I had severe pre-eclampsia and am diagnosed with a chronic extremely low vitamin D level. It is so low that I have to take ... Of the women with pre-eclampsia, 54 percent were also found to have low vitamin D levels. For the healthy pregnant women, only ... New research may have found a link between vitamin D and early-onset severe pre-eclampsia. The dangerous condition, which ...
Multiple small studies have suggested that women with pre-eclampsia present elevated levels of C-reactive protein (CRP) and ... Pre-eclampsia was defined as presence of blood pressure ≥140/90 mmHg and proteinuria ≥300mg/24 h (or ≥1 + dipstick). There was ... C-reactive protein, interleukin-6 and pre-eclampsia: large-scale evidence from the GenPE case-control study Scand J Clin Lab ... Therefore, the aim of this study was to evaluate the relationship between CRP and IL-6 levels with pre-eclampsia considering ...

No FAQ available that match "pre eclampsia"

No images available that match "pre eclampsia"